InvestorQ : Can you throw some light on the deal between Emergent and AstraZeneca?
shrinidhi Rajan made post

Can you throw some light on the deal between Emergent and AstraZeneca?

Answer
user profile image
Riya Dwivedi answered.
3 months ago


Emergent BioSolutions has signed a $174 million deal with AstraZeneca to develop and manufacture Astra’s COVID-19 vaccine candidate. Emergent will produce 300 million doses of its potential COVID-19 vaccine pledged to the US. Astra has committed 2 billion doses of the vaccine. The vaccine has been co-developed by Oxford University and is among the first to move into mid-stage trials.